WHO ICTRP trial
Retropatellar cartilage defects with matrix-augmented bone marrow stimulation…
DRKS00021490 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00021490 |
|---|---|
| Public title | Retropatellar cartilage defects with matrix-augmented bone marrow stimulation (Hyalofast®) |
| Scientific title | Retropatellar cartilage defects with matrix-augmented bone marrow stimulation (Hyalofast®) |
| Primary sponsor | Medizinische Hochschule Hannover |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | Chondromalacia : lower leg [fibula, tibia, knee joint]. M23.9;Internal derangement of knee, unspecified;M23.9 |
| Interventions | Group 1: Patients who have undergone matrix augmented bone marrow stimulation with HyaloFast® due to focal chondromalacia III-IV Preoperatively, the following general patient data are determined: - Demographic data (gender, age… |
| Registration date | Sep 17, 2020 |
| Target size | 34 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: